Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Inverse docking approach identifies lanosterol synthase as new target for anticancer agents

March 3, 2011

Selexagen discloses new sonic hedgehog protein inhibitors

March 2, 2011

Seattle Genetics and Millennium begin phase I trial of brentuximab vedotin

March 2, 2011

Gemzar approved in Japan for ovarian cancer after chemotherapy

March 2, 2011

FDA grants Epeius' anticancer gene therapy Rexin-G phase III status

March 2, 2011

RITA has synergistic activity with chemotherapeutic agents in MM cells in vitro

March 2, 2011

Germline SNPs inked to outcome of docetaxel-treated metastatic castration-resistant prostate cancer

March 2, 2011

Seattle Genetics submits BLA for brentuximab in Hodgkin's and large cell lymphoma

March 1, 2011

New inhibitors of tyrosine-protein kinase JAK enzymes claimed

March 1, 2011

FDA grants priority review for Istodax sNDA in peripheral T-cell lymphoma

March 1, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...